Men | 74.7% | 83.8% | 0.06 |
Age (years) | 59.7 (11.7) | 59.2 (12.1) | 0.7 |
Diabetes | 10.8% | 3.7% | 0.02 |
Current smoking | 45.7% | 44.9% | 0.9 |
Hypercholesterolaemia | 33.9% | 30.1% | 0.5 |
Hypertension | 24.2% | 20.6% | 0.5 |
Previous myocardial infarction | 14.4% | 10.6% | 0.4 |
Previous PCI | 6.5% | 5.9% | 1.0 |
Previous CABG | 1.6% | 2.2% | 0.7 |
Coronary artery disease | | | 0.9 |
1 vessel | 54.8% | 52.2% | |
2 vessel | 27.4% | 28.7% | |
3 vessel | 17.7% | 19.1% | |
Cardiogenic shock | 13.4% | 11.8% | 0.7 |
Time from symptom onset to PCI (hours) | 3.2 (1.9) | 3.1 (2.4) | 0.7 |
Infarct related vessel | | | 0.6 |
LAD | 52.7% | 51.5% | |
LCx | 8.2% | 8.8% | |
RCA | 37.4% | 36.0% | |
Left main stem | 1.6% | 2.2% | |
Saphenous vein graft | 0% | 1.5% | |
Bifurcation lesion | 8.6% | 9.6% | 0.8 |
Number of vessels treated | | | 1.0 |
1 | 84.9% | 86.0% | |
>1 | 15.1% | 14.0% | |
TIMI flow baseline grade | | | 0.4 |
0–1 | 73.1% | 78.7% | |
2 | 16.5% | 11.0% | |
3 | 10.4% | 10.3% | |
TIMI flow final grade | | | 0.7 |
0–1 | 2.1% | 2.2% | |
2 | 14.8% | 11.8% | |
3 | 83.0% | 86.0% | |
Number of stents | 1.9 (1.2) | 1.8 (1.1) | 0.4 |
Total stented length (mm) | 34.7 (23.5) | 35.9 (22.9) | 0.6 |
Mean nominal stent diameter (mm) | 2.89 (0.16) | 3.11 (0.33) | <0.001 |
Glycoprotein IIb/IIIa inhibitor | 36.6% | 55.1% | 0.001 |
Peak CK (IU) | 3126 (3126) | 3234 (2567) | 0.8 |
Peak CK-MB (IU) | 296 (255) | 359 (330) | 0.2 |